GB201122408D0 - Method for preparing dry protein formulations - Google Patents

Method for preparing dry protein formulations

Info

Publication number
GB201122408D0
GB201122408D0 GB201122408A GB201122408A GB201122408D0 GB 201122408 D0 GB201122408 D0 GB 201122408D0 GB 201122408 A GB201122408 A GB 201122408A GB 201122408 A GB201122408 A GB 201122408A GB 201122408 D0 GB201122408 D0 GB 201122408D0
Authority
GB
United Kingdom
Prior art keywords
protein formulations
preparing dry
dry protein
amorphous precipitated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201122408A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Priority to GB201122408A priority Critical patent/GB201122408D0/en
Publication of GB201122408D0 publication Critical patent/GB201122408D0/en
Priority to EP12816095.9A priority patent/EP2793863B1/en
Priority to IN1377MUN2014 priority patent/IN2014MN01377A/en
Priority to CA2859288A priority patent/CA2859288A1/en
Priority to DK12816095.9T priority patent/DK2793863T3/en
Priority to BR112014015357A priority patent/BR112014015357A2/pt
Priority to US14/367,088 priority patent/US20140348852A1/en
Priority to JP2014548209A priority patent/JP2015500869A/ja
Priority to PCT/GB2012/053265 priority patent/WO2013093524A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB201122408A 2011-12-23 2011-12-23 Method for preparing dry protein formulations Ceased GB201122408D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB201122408A GB201122408D0 (en) 2011-12-23 2011-12-23 Method for preparing dry protein formulations
EP12816095.9A EP2793863B1 (en) 2011-12-23 2012-12-24 Method for preparing amorphous precipitated protein particles
IN1377MUN2014 IN2014MN01377A (https=) 2011-12-23 2012-12-24
CA2859288A CA2859288A1 (en) 2011-12-23 2012-12-24 Method for preparing amorphous precipitated protein particles
DK12816095.9T DK2793863T3 (en) 2011-12-23 2012-12-24 PROCEDURE FOR THE PREPARATION OF AMORPH PRECIPTATED PROTEIN PARTICLES
BR112014015357A BR112014015357A2 (pt) 2011-12-23 2012-12-24 método para a preparação de partículas de proteína precipitada amorfa
US14/367,088 US20140348852A1 (en) 2011-12-23 2012-12-24 Method for making precipitated particles
JP2014548209A JP2015500869A (ja) 2011-12-23 2012-12-24 アモルファス性沈殿タンパク質粒子の調製方法
PCT/GB2012/053265 WO2013093524A2 (en) 2011-12-23 2012-12-24 Method for preparing amorphous precipitated protein particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201122408A GB201122408D0 (en) 2011-12-23 2011-12-23 Method for preparing dry protein formulations

Publications (1)

Publication Number Publication Date
GB201122408D0 true GB201122408D0 (en) 2012-02-08

Family

ID=45695047

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201122408A Ceased GB201122408D0 (en) 2011-12-23 2011-12-23 Method for preparing dry protein formulations

Country Status (9)

Country Link
US (1) US20140348852A1 (https=)
EP (1) EP2793863B1 (https=)
JP (1) JP2015500869A (https=)
BR (1) BR112014015357A2 (https=)
CA (1) CA2859288A1 (https=)
DK (1) DK2793863T3 (https=)
GB (1) GB201122408D0 (https=)
IN (1) IN2014MN01377A (https=)
WO (1) WO2013093524A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174458B2 (en) * 2007-04-23 2021-11-16 Koligo Therapeutics, Inc. Cell separation apparatus and methods of use
GB201313368D0 (en) * 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
US11654112B2 (en) 2016-11-22 2023-05-23 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
AU2018306303A1 (en) 2017-07-25 2020-02-20 Elektrofi, Inc. Formation of particles including agents
KR20200143449A (ko) * 2018-04-16 2020-12-23 메르크 파텐트 게엠베하 메글루민 염을 사용하여 단백질을 포함하는 제형을 안정화시키는 방법
US11103552B2 (en) 2018-05-10 2021-08-31 Regeneron Pharmaceuticals, Inc. High concentration VEGF receptor fusion protein containing formulations
WO2019226969A1 (en) 2018-05-24 2019-11-28 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3917500A2 (en) 2019-01-31 2021-12-08 Elektrofi, Inc. Particle formation and morphology
KR102941878B1 (ko) * 2019-02-05 2026-03-23 린디 바이오사이언시스, 아이엔씨. 단리된 세포 배양 성분 및 액체 세포 배양 배지로부터 이를 단리하는 방법
WO2021050953A1 (en) 2019-09-13 2021-03-18 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
JP2023522627A (ja) 2020-04-17 2023-05-31 エレクトロフィ，インコーポレイテッド 連続的な液滴形成及び脱水によって粒子を形成する方法
CN115844752B (zh) * 2022-11-02 2024-06-28 上海铂舍生物科技有限公司 一种5d超分子胶原蛋白及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0300427D0 (en) 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions

Also Published As

Publication number Publication date
BR112014015357A2 (pt) 2017-07-11
EP2793863A2 (en) 2014-10-29
WO2013093524A3 (en) 2013-08-15
JP2015500869A (ja) 2015-01-08
CA2859288A1 (en) 2013-06-27
EP2793863B1 (en) 2018-07-25
DK2793863T3 (en) 2018-11-12
US20140348852A1 (en) 2014-11-27
WO2013093524A2 (en) 2013-06-27
IN2014MN01377A (https=) 2015-04-17

Similar Documents

Publication Publication Date Title
GB201122408D0 (en) Method for preparing dry protein formulations
EP2773746A4 (en) COMPOSITIONS OF ADULT MESENCHYMAL STEM CELLS (MSC) AND PREPARATION METHODS THEREOF
IN2015KN00262A (https=)
MX2013009175A (es) Composiciones que comprenden acido peroxi alfa-cetocarboxilico y metodos para producirlas y usarlas.
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
MY167953A (en) Flavoured rods for use in aerosol-generating articles
MY166059A (en) Fusion Proteins for Treating Metabolic Disorders
IL230477A0 (en) Process for preparing 2,2-difluoroethanol
MY168396A (en) Smoking article comprising menthol
ZA201403109B (en) Modulating beta-damascenone in plants
EP2665818A2 (en) Protein expression in plants
WO2011085247A3 (en) Vectors and methods for transducing b cells
PL2768935T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
IN2014DN00180A (https=)
AU340459S (en) Teat for baby bottle
ZA201300275B (en) Methods for producing proteins in plants
EP2663288A1 (en) Methods for preparing vesicles and formulations produced therefrom
ZA201403059B (en) Increasing virus-like particle yield in plants
ZA201404560B (en) Process for preparing sodium bicarbonate particles
PL2714327T3 (pl) Ulepszenia sposobów ostrzenia noży
PH12015501132A1 (en) Improved methods for inducing apomixis in plants
AU2012201606B2 (en) Crystalline levofolinic acid and process for its preparation
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
WO2013076729A8 (en) Otomeria plants
PH12014500432A1 (en) Stable compositions and methods for preparing the same

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)